Report highlighting New Jersey’s infrastructure supporting startups
| UNION, N.J., July 18, 2018 /PRNewswire/ -- Today, the Institute for Life Science Entrepreneurship (ILSE) announced the publication of its report highlighting life science incubator space and innovation trends in the Garden State. Entitled “Recent Advances in Laboratory and Innovation Space in New Jersey”, the paper includes profiles of major biopharma incubators and innovation spaces in New Jersey and perspectives from leaders of successful industrial and academic incubators as well as the recognized biopharma industry organization, BioNJ, all who support prioritizing investment in infrastructure for biopharma start-ups. The white paper summarizes existing and new developments and identifies recent physical build outs designed to promote life science innovation in the state. Notably, it includes an inventory of key laboratory and work spaces listing R&D areas of focus, physical space specifications, unique or specific amenities, and opportunities for entrepreneurs to launch innovative new companies. With clear support from Governor Phil Murphy, economic incentives through the New Jersey Economic Development Authority, and the many biopharma companies interested in the next wave of discoveries, the state is well-positioned to support increased incubator space for life science startups and entrepreneurs. “We are delighted to publish this white paper and encouraged by the trends in New Jersey to increase innovation space” said Keith Bostian, Founder and CEO, ILSE. “We look forward to building on what we have created at ILSE and continuing to work with key leaders in our ecosystem to help life science visionaries develop successful new companies and promote the innovation economy.” The white paper is available for viewing at https://ilsebio.com/innovation-in-new-jersey/ (and can also be requested as a PDF by contacting Thomas Richardson, President, ILSE, at trichardson@ilsebio.com). About ILSE: The Institute for Life Science Entrepreneurship (ILSE) is a non-profit 501(c)(3) focused on accelerating life science discoveries to improve human health, including new medicines, devices and transformative technologies. ILSE is a life science accelerator and a science-driven research institute, and houses a business incubator. ILSE works in partnership with major academic, non-profit, and corporate organizations, and with entrepreneurs and regional institutions by providing consulting expertise via a network of global life science experts and a network of R&D service organizations. ILSE’s ATCC Center for Translational Microbiology focuses on cutting-edge research in microbiome, advanced microbial genomics, clinical MDR antibiotic resistance, and bioinformatics. ILSE is located in Union, NJ, on the campus of Kean University, approximately 25 min from New York City. Contact: Thomas Richardson
View original content with multimedia:http://www.prnewswire.com/news-releases/institute-for-life-science-entrepreneurship-releases-white-paper-titled-recent-advances-in-laboratory-and-innovation-space-in-new-jersey-300682672.html SOURCE Institute for Life Science Entrepreneurship |
